Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00349505

Enrollment

Registered

2006-07-07

Start date

2004-09-30

Completion date

Unknown

Last updated

2006-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epithelial Ovarian Carcinoma, Figo Stage IIIC

Keywords

previous treatment surgery + 6 cycles of platinum based chemotherapy

Brief summary

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy. A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

Interventions

PROCEDUREhyper thermic chemo + surgery

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy \-

Exclusion criteria

* Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look

Countries

France

Contacts

Primary ContactDominique ELIAS, MD, PhD

elias@igr.fr00 33 014-211-5441

Backup ContactAnnie REY

rey@igr.fr00 33 014-211-4137

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026